CBD and alcohol: what the state of the research really says

The founding study goes back to 1979. Consroe and colleagues gave ten healthy volunteers, in a double-blind crossover design, a placebo, 200 mg of CBD, alcohol at a rate of one gram per kilogram, or the two combined.

Its main result is rarely quoted correctly: alcohol, and the alcohol plus CBD combination, but not CBD alone, produced significant impairments of motor and psychomotor performance. CBD therefore did not attenuate the impairment induced by alcohol. The authors did also report lower blood alcohol levels with the combination, while concluding that cannabidiol was inactive. It is from that single observation, on ten people almost fifty years ago, that the widespread claim that CBD lowers blood alcohol levels descends.

The claim has been put to the test. A placebo-controlled crossover trial, published in 2023 in Psychopharmacology, had thirty-six heavy drinkers receive 30 mg of CBD, 200 mg of CBD or a placebo before a standardised dose of alcohol. The authors conclude that CBD has a minimal influence both on breath-measured blood alcohol and on the subjective effects of alcohol.

The contrast is clear. An isolated observation from 1979 on ten subjects, a negative result in 2023 on thirty-six: the weight of the evidence does not lean the way the marketing suggests.

This is where most of the shortcuts are born. A French narrative review published in 2019 in Frontiers in Pharmacology takes stock: experimental studies show that CBD reduces the overall level of alcohol consumption in animal models, and document a reduction in alcohol-related hepatic steatosis and fibrosis, as well as in the associated brain damage. The authors explicitly conclude that any other application warrants trials in humans.

An umbrella review of twenty-two systematic reviews, published in 2025 in Addiction, points the same way: cannabidiol monotherapy does not appear effective in the treatment of substance use disorders, and the data remain limited and inconclusive for alcohol as much as for tobacco or cannabis.

In other words, what is observed in animals has not been confirmed in humans. Saying otherwise would be an extrapolation.

On one point, by contrast, the regulatory documentation is unambiguous. The summary of product characteristics for Epidyolex, published by the European Medicines Agency, states that cannabidiol may cause somnolence and sedation, and that other central nervous system depressants, including alcohol, may potentiate this effect. The same document specifies that cannabidiol has a major influence on the ability to drive and use machines.

Two qualifications are needed when reading it. This document concerns a medicine prescribed at doses of 10 to 25 mg per kilogram per day, far above those of a consumer product. And it mentions, in its section on adverse effects, an incidence of transaminase elevations above three times the upper limit of normal of 12 % in treated patients against less than 1 % on placebo, which is an invitation not to present cannabidiol as a liver protector. We develop this subject in our article on CBD and liver enzymes.

Whatever question is asked about CBD, the alcohol consumption guidance does not change. Santé publique France recommends not exceeding ten standard drinks per week and two standard drinks per day, and planning days without any consumption. A standard drink contains ten grams of pure alcohol, whatever the beverage. The agency also recalls that there is no risk-free level of alcohol consumption.

We found no position from the ANSM, the HAS or INSERM bearing specifically on the combination of CBD and alcohol. For a personal health question, speak to a professional. Our article on drug interactions details the pharmacological side, the one devoted to alcohol and cannabis compares the two substances, and the one on Dry January addresses the question of the aperitif ritual.

Does CBD lower the level of alcohol in the blood?

This idea comes from a single 1979 study involving ten people, whose authors moreover concluded that cannabidiol was inactive. The most recent trial, published in 2023 on thirty-six participants, concludes that CBD has a minimal influence on breath-measured blood alcohol. As the literature stands, the claim is not supported.

Does CBD protect the liver from the effects of alcohol?

The work that suggests it is experimental and concerns animal models: the 2019 review that surveys it explicitly concludes that any other application warrants trials in humans. Conversely, the European Medicines Agency documentation reports, for a high-dose cannabidiol medicine, an incidence of transaminase elevations of 12 % against less than 1 % on placebo.

Can you drive after taking CBD and drinking alcohol?

The European regulatory documentation states that cannabidiol has a major influence on the ability to drive, and that alcohol may potentiate its drowsiness. Legally, the offence of driving after using narcotics targets THC, which may be present in trace amounts in a CBD product. The two reasons converge on the same practical conclusion.